Nova Leap Health Corp.
NLH.VTSXVHealthcare● Active
$0.37
+$0.00(+0.00%)
Market Cap$32306273
P/E Ratio—
52W High$0.44
52W Low$0.22
Nova Leap Health Corp. (NLH.V) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NLH.V · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.01
Est. -$0.00 · +503.1%
Revenue
$0.01B
Est. $0.01B · +69.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
NLH.V reports quarterly as a TSXV-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.00 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.00 | $0.01 | +503.1% | $0.01B | $0.01B | +69.0% |
| — Q1 FY2026 | Mar 5, 2026 | — | -$0.00 | — | $0.01B | $0.01B | -4.2% |
| — Q3 FY2025 | Aug 7, 2025 | — | -$0.01 | — | $0.01B | — | — |
| — Q2 FY2025 | May 8, 2025 | — | -$0.00 | — | $0.01B | — | — |
| — Q1 FY2025 | Mar 5, 2025 | — | $0.01 | — | $0.01B | $0.01B | -4.0% |
| — Q4 FY2024 | Nov 7, 2024 | — | -$0.00 | — | $0.01B | $0.01B | -5.5% |
| — Q3 FY2024 | Aug 8, 2024 | — | $0.00 | — | $0.01B | $0.01B | -3.7% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.00
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.01
EPS Est.
-$0.00
EPS Surpr.
+503.1%
Revenue
$0.01B
Q1 FY2026
Mar 5, 2026
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2025
Aug 7, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
May 8, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Mar 5, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2024
Nov 7, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2024
Aug 8, 2024
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2030 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2030 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +503.1% | $0.36 | $0.36 | +0.00% |
| — Q1 FY2026 | Mar 5, 2026 | — | $0.31 | $0.35 | +11.29% |
| — Q3 FY2025 | Aug 7, 2025 | — | $0.22 | $0.23 | +2.27% |
| — Q2 FY2025 | May 8, 2025 | — | $0.30 | $0.30 | +0.00% |
| — Q1 FY2025 | Mar 5, 2025 | — | $0.23 | $0.23 | +0.00% |
| — Q4 FY2024 | Nov 7, 2024 | — | $0.33 | $0.32 | -3.03% |
| — Q3 FY2024 | Aug 8, 2024 | — | $0.33 | $0.29 | -13.64% |
| — Q2 FY2024 | May 9, 2024 | — | $0.26 | $0.26 | +0.00% |
Q2 FY2026+0.00%
Report Date
May 7, 2026
EPS Beat/Miss
+503.1%
Price Before
$0.36
Price After
$0.36
Q1 FY2026+11.29%
Report Date
Mar 5, 2026
EPS Beat/Miss
—
Price Before
$0.31
Price After
$0.35
Q3 FY2025+2.27%
Report Date
Aug 7, 2025
EPS Beat/Miss
—
Price Before
$0.22
Price After
$0.23
Q2 FY2025+0.00%
Report Date
May 8, 2025
EPS Beat/Miss
—
Price Before
$0.30
Price After
$0.30
Q1 FY2025+0.00%
Report Date
Mar 5, 2025
EPS Beat/Miss
—
Price Before
$0.23
Price After
$0.23
Q4 FY2024-3.03%
Report Date
Nov 7, 2024
EPS Beat/Miss
—
Price Before
$0.33
Price After
$0.32
Q3 FY2024-13.64%
Report Date
Aug 8, 2024
EPS Beat/Miss
—
Price Before
$0.33
Price After
$0.29
Q2 FY2024+0.00%
Report Date
May 9, 2024
EPS Beat/Miss
—
Price Before
$0.26
Price After
$0.26
Avg Beat Reaction+0.00%
Beat Rate1 / 8 quarters
Largest Move-13.64% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NLH.V ends December
Nova Leap Health Corp. (NLH.V) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.01 — beating the analyst consensus of $-0.00 by +503.1%. The next NLH.V earnings date is expected around September 1, 2026.
Each quarter, investors track NLH.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NLH.V revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NLH.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NLH.V earnings · 5 questionsNova Leap Health Corp.'s next earnings report is expected around September 1, 2026. NLH.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NLH.V historically reports after market close (AMC).
NLH.V earnings datewhen is NLH.V earningsNLH.V next earnings datewhen does NLH.V report earningsNLH.V earnings calendar
▸ Source: FMP · Nova Leap Health Corp. SEC filings · US GAAP · Nova Leap Health Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026